Physician profile
Ashley Sweeney
NPI 1083144976
$1,852.16
in general payments reported to CMS, 2019-2025
7 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $176 · 2024: $484 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208 · Travel and Lodging: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.67 |
| Travel and Lodging | $644.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $814.26 | 2025 | Optablate, Spinejack, Triever20 |
| Boston Scientific Corporation | $577.89 | 2023-2025 | Embold Fibered, Avvigo Guidance System |
| Sirtex Medical INC | $208.99 | 2025 | Lava Les (Liquid Embolic System) |
| Penumbra, INC. | $98.52 | 2024 | Indigo System |
| Abbott Laboratories | $63.52 | 2025 | Esprit, Supera, Absolute Pro |
| Argon Medical Devices, INC. | $50.48 | 2023 | Cleaner |
| Trisalus Life Sciences, INC. | $38.50 | 2025 | Trinav Infusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.